0001209191-23-045630.txt : 20230814
0001209191-23-045630.hdr.sgml : 20230814
20230814162420
ACCESSION NUMBER: 0001209191-23-045630
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klassen Preston
CENTRAL INDEX KEY: 0001493056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 231170728
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES COURT, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4224 CAMPUS POINT COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 4224 CAMPUS POINT COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-10
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001493056
Klassen Preston
C/O REGULUS THERAPEUTICS INC.
4224 CAMPUS POINT CT., #210
SAN DIEGO
CA
92121
1
1
0
0
President & Head of R & D
0
Stock Option (Right to Buy)
1.36
2023-08-10
4
A
0
225000
0.00
A
2033-08-09
Common Stock
225000
225000
D
The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Christopher Aker, Attorney in Fact
2023-08-14